Search clinical trials for: placebo of AD-208

Total 30011 results

Addpharma Inc.

Completed

A Study to Evaluate the Efficacy and Safety of AD-208

Androgenetic Alopecia

Korea, Republic of
Addpharma Inc.

Completed

A Study to Evaluate the Efficacy and Safety of AD-209

Hypertension, Essential

Korea, Republic of
Addpharma Inc.

Recruiting

Phase III Study to Evaluate the Efficacy and Safety of AD-209

Hypertension,Essential

Korea, Republic of
Addpharma Inc.

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of AD-224

Hypertension,Essential
Addpharma Inc.

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B

Essential Hypertension
Addpharma Inc.

Recruiting

A Study to Evaluate the Efficacy and Safety of AD-218

Mixed Dyslipidemia

Korea, Republic of
Zhejiang Hisun Pharmaceutical Co. Ltd.

Unknown

Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease (WAY)

Alzheimer's Disease

China
TScan Therapeutics, Inc.

Recruiting

A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors

Melanoma | Cervical Cancer | Head and Neck Cancer | HPV-Related Malignancy | Ovarian Cancer | HPV-Related Carcinoma | HPV-Related Cervical Carcinoma | HPV Positive Oropharyngeal Squamous Cell Carcinoma | Non-small Cell Carcinoma | HPV - Anogenital Human Papilloma Virus Infection | HPV-Related Adenocarcinoma | HPV-Related Adenosquamous Carcinoma and other conditions

United States
Addpharma Inc.

Recruiting

A Study to Evaluate the Efficacy and Safety of AD-223

Hypertension,Essential

Korea, Republic of
Addpharma Inc.

Completed

Phase 3 Study to Evaluate the Efficacy and Safety of Co-administrated AD-2021 and AD-2022

Hypertension, Essential | Primary Hypercholesterolemia

Korea, Republic of
Addpharma Inc.

Completed

Evaluating the Pharmacokinetic Interaction Between AD-2011 and AD-2012

Hypertension | Hyperlipidemias

Korea, Republic of
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Department of Health and Human Services

Terminated

Wild Type p53 Adenovirus for Oral Premalignancies

Mouth Cancer

United States
Addpharma Inc.

Completed

A Study to Evaluate the Efficacy and Safety of AD-203

Acute Gastritis | Chronic Gastritis

Korea, Republic of
Abbott Nutrition

Completed

Evaluation of AN777 in Elderly Subjects

Aged

United States
Samus Therapeutics, Inc.

Terminated

A Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of PU-AD in Healthy Subjects

Alzheimer's Disease

United States
AdAlta Limited

Completed

Safety, Tolerability, PK and PD Study of AD-214 Administered to Healthy Volunteers and Patients With Interstitial Lung Disease or Chronic Kidney Disease

Chronic Kidney Diseases | Interstitial Lung Disease

Australia
AdAlta Limited

Completed

Phase 1 Safety, Tolerability, PK & PD Study of AD-214 Administered to Healthy Volunteers

Interstitial Lung Disease

Australia
Hunazine Biotech S.L.

Recruiting

Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera

Cholera

Bangladesh
Kang Stem Biotech Co., Ltd.

Completed

Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis(AD)

Atopic Dermatitis

Korea, Republic of
PiLeJe

Completed

Exploratory Study on Lactibiane Topic AD on Skin Flora and Barrier Reinforcement in Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

France
Addpharma Inc.

Completed

A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole

Gastritis

Korea, Republic of
Alzheimer's Disease Expert Lab (ADEL), Inc.
Oscotec Inc.

Recruiting

A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01

Alzheimer Disease

United States
Resverlogix Corp

Not yet recruiting

A Two-Part Phase 2a Study of RVX000222 in Patients With End-Stage Renal Disease Treated With Hemodialysis

Kidney Failure, Chronic
Zhejiang Hisun Pharmaceutical Co. Ltd.
Medpace, Inc.

Unknown

Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease (ROAD)

Alzheimer Disease, Early Onset

United States
Samus Therapeutics, Inc.

Withdrawn

Evaluate PU-AD in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)
Takeda

Completed

A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322

Diabetes Mellitus

Japan
Navy General Hospital, Beijing
Peking Union Medical College Hospital; Cancer Institute and Hospital, Chinese... and other collaborators

Unknown

Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia

Severe Aplastic Anemia

China
Allon Therapeutics

Completed

Study to Evaluate Safety, Tolerability, and Effect of AL208 on Mild Cognitive Impairment Following Coronary Artery Bypass Graft Surgery

Mild Cognitive Impairment

United States, Canada
University of California, San Diego
Memgen, LLC

Completed

Pharmacodynamic (PD) Study of Intranodal Adenovirus-CD154 (Ad-ISF35) in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Hospices Civils de Lyon

Completed

Predictive Value of Biomarkers of the Alzheimer's Disease (AD) in Elderly Patients With New-onset Epilepsy (BIOMALEPSIE)

Epilepsy

France
Resverlogix Corp
Nucleus Network Ltd; Baker Heart and Diabetes Institute

Completed

The Effects of RVX000222 on Glucose Metabolism in Individuals With Pre-diabetes

Diabetes

Australia
Vaxart

Completed

Safety Study of an Oral Vaccine to Prevent Avian Influenza (H5N1)

Avian Influenza | Bird Flu

United States
Addpharma Inc.

Completed

A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A

Primary Hypercholesterolemia

Korea, Republic of
Takeda

Terminated

AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease

Mild Cognitive Impairment Due to Alzheimer's Disease

United States, Australia, United Kingdom, Switzerland
University of Florida
Lallemand Bio-Ingredients

Completed

Fermented Soy and Heartburn Symptom Relief

Heartburn | Acid Regurgitation

United States
Resverlogix Corp

Completed

Clinical Trial for Dose Finding and Safety of RVX000222 in Subjects With Stable Coronary Artery Disease (ASSERT)

Coronary Artery Disease | Atherosclerosis

United States
Takeda

Completed

Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly Participants

Healthy

United States
Shenzhen Bay Laboratory
National Natural Science Foundation of China; Guangdong Basic and Applied Basic... and other collaborators

Recruiting

Greater-Bay-Area Healthy Aging Brain Study (GHABS) (GHABS)

Alzheimer's Disease

China
University of Michigan Rogel Cancer Center
Phase One Foundation

Completed

Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma

Glioblastoma Multiforme | Malignant Glioma

United States
Kang Stem Biotech Co., Ltd.

Recruiting

Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD) (smart(FURIN))

Dermatitis, Atopic

Korea, Republic of
Translational Research Center for Medical Innovation...
Daiichi Sankyo Co., Ltd.

Completed

Exploratory Study for the Validity of QuQu Scale (QuQu)

Alzheimer Dementia

Japan
Myles Wolf
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Completed

Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)

Kidney Disease

United States
Resverlogix Corp

Completed

Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol

Cardiovascular Disease | Atherosclerosis | Dyslipidemia | Acute Coronary Syndrome

United States
Northwestern University

Completed

Acupressure in Pruritus for Atopic Dermatitis

Atopic Dermatitis

United States
University Hospital, Montpellier

Recruiting

A Prospective Cohort Study of Patients Suffering From Hand Osteoarthritis Symptoms (COARDIG)

Hand Osteoarthritis

France
Addpharma Inc.

Completed

To Evaluate the Pharmacokinetics and Safety of AD-208

Androgenetic Alopecia

Korea, Republic of
Orion Corporation, Orion Pharma

Completed

Effect of Moisturising Creams on Skin Moisture in Atopic Dermatitis

Dermatitis, Atopic

Finland
Hookipa Biotech GmbH

Recruiting

A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers

HPV-Related Squamous Cell Carcinoma

United States, Spain, Netherlands
Crucell Holland BV
The PATH Malaria Vaccine Initiative (MVI); Seattle Children's Research Institute...

Completed

A Study to Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge Model

Malaria

United States
PegBio Co., Ltd.

Completed

Clinical Trial for the Investigational Drug (PB-201) in Subjects With Type 2 Diabetes Mellitus

Type2 Diabetes Mellitus

China

Search clinical trials for: placebo of AD-208

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations